Abel R. Costa
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara-VTd) induction and lenalidomide maintenance in transplant-eligible multiple myeloma.
Journal: British journal of haematology
Published: May 19, 2026
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.
Journal: Lancet (London, England)
Published: October 24, 2025
Favorable outcomes of restrictive treatment indications in chronic lymphocytic leukemia: a retrospective analysis of Brazilian Registry of CLL.
Journal: Lancet regional health. Americas
Published: April 10, 2025
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH).
Journal: Hematology, transfusion and cell therapy
Published: March 21, 2025
Real-world data on the use of subcutaneous daratumumab plus bortezomib, thalidomide, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma.
Journal: Annals of hematology
Published: January 28, 2025
Post-resistance exercise hemodynamic and autonomic responses: Comparison between normotensive and hypertensive men.
Journal: Scandinavian journal of medicine & science in sports
Published: May 28, 2014
Amlodipine reduces blood pressure during dynamic resistance exercise in hypertensive patients.
Journal: Scandinavian journal of medicine & science in sports
Published: October 17, 2013
Cardiac work remains high after strength exercise in elderly.
Journal: International journal of sports medicine
Published: November 24, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026